Inhibition of NF-κB sensitizes non–small cell lung cancer cells to chemotherapy-induced apoptosis
- 1 September 2000
- journal article
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 70 (3), 930-936
- https://doi.org/10.1016/s0003-4975(00)01635-0
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- NF-κB Antiapoptosis: Induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to Suppress Caspase-8 ActivationScience, 1998
- The Role of Nuclear Factor- κ B in Cytokine Gene RegulationAmerican Journal of Respiratory Cell and Molecular Biology, 1997
- Activation of NF-κB by Antineoplastic AgentsJournal of Biological Chemistry, 1997
- IκB proteins: structure, function and regulationSeminars in Cancer Biology, 1997
- Role of oncogenes in resistance and killing by cancer therapeutic agentsCurrent Opinion in Oncology, 1997
- TNF- and Cancer Therapy-Induced Apoptosis: Potentiation by Inhibition of NF-κBScience, 1996
- THE NF-κB AND IκB PROTEINS: New Discoveries and InsightsAnnual Review of Immunology, 1996
- Chemotherapy in non-small cell lung cancer: a meta-analysis using updated data on individual patients from 52 randomised clinical trialsBMJ, 1995
- New aspects in the staging of lung cancer. Prospective validation of the international union against cancer TNM classificationCancer, 1992